UBE2I and neoplasm: Our previous study demonstrated that ablation of UBC9 in tumor-associated macrophages could reverse the immunosuppressive phenotype of the prostate by promoting macrophage activation and CD8+ T cell infiltration, which revealed an inextricable relationship between SUMOylation and tumor microenvironment (TME) [17].